This article first appeared on GuruFocus.
-
Total Income (Q3 2026): $46.9 million, down 4% year over year.
-
Royalty Income (Q3 2026): Declined 2% year over year; core asset royalty income grew 3% in the quarter and 8% year-to-date.
-
Normalized Total Cash Receipts (Q3 2026): $47.5 million, up 9% year over year.
-
Total Cash Receipts Including Ekterly Sale (Q3 2026): $223.7 million.
-
Adjusted EBITDA (Q3 2026): $40.0 million, up 9% year over year; margin of 84% (86% excluding incentive accrual).
-
Net Earnings (Q3 2026): $46.5 million, or $0.85 per unit.
-
Comprehensive Earnings (Q3 2026): $49.7 million, versus a comprehensive loss of $57.7 million last year.
-
Total Expenses (Q3 2026): $59.2 million, essentially flat year over year.
-
Compensation Expense (Q3 2026): $4.1 million, up $500,000 year over year.
-
Interest Expense (Q3 2026): $8.5 million, down 17% year over year; Q4 credit facility interest expected at approximately $4.3 million.
-
Zejula Impairment: Non-cash impairment of $14.6 million recorded in the quarter.
-
Ekterly Sale Gain: $59.9 million gain on sale, representing $176.2 million of proceeds against a net book value of $116.3 million.
-
Income Tax Expense (Q3 20...